ADENOSQUAMOUS CELL LUNG CANCER

This adverse event was reported 48 times

These drugs are most commonly taken by patients reporting ADENOSQUAMOUS CELL LUNG CANCER:

# Drug Count
0 LENALIDOMIDE 7
1 MELPHALAN 7
2 MELPHALAN HYDROCHLORIDE 7
3 BUSULFAN 5
4 INFLIXIMAB 5
5 NINTEDANIB 5
6 AMOXICILLIN 4
7 CEFAZOLIN SODIUM 4
8 DENOSUMAB 4
9 ENOXAPARIN SODIUM 4
See all common drugs associated with ADENOSQUAMOUS CELL LUNG CANCER

ADENOSQUAMOUS CELL LUNG CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAPMATINIB 1 0.0004
1 CEFAZOLIN SODIUM 4 0.0003
2 BARICITINIB 1 0.0003
3 BUSULFAN 5 0.0003
4 MELPHALAN HYDROCHLORIDE 7 0.0003
5 NINTEDANIB 5 0.0002
6 GEFITINIB 1 0.0001
7 DASATINIB 1 0.0001
8 PITAVASTATIN CALCIUM 1 0.0001
9 CRIZOTINIB 1 0.0001
See all drugs enriched for association with ADENOSQUAMOUS CELL LUNG CANCER